Zometa

ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects
ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects
Yahoo/Benzinga
Fertility
cancer
ASCO
Zoladex
AstraZeneca
Novartis
Zometa
Flag link:
Jury is out in another case linking Novartis' Zometa to jawbone death
Jury is out in another case linking Novartis' Zometa to jawbone death
Fierce Pharma
Zometa
Novartis
Flag link:
Dr. Reddy's labs launches generic Zometa in US
Dr. Reddy's labs launches generic Zometa in US
Pharmaceutical Business Review
Dr Reddy's
Zometa
generics
Flag link:
Novartis Sues Sun Over Proposed Generic Zometa, Reclast
Novartis Sues Sun Over Proposed Generic Zometa, Reclast
Bloomberg
Sun Pharma
Novartis
generics
Reclast
Zometa
Flag link:
Anemic Growth? Not From These Drugs.
Anemic Growth? Not From These Drugs.
Motley Fool
Amgen
Affymax
Takeda
Epogen
Aranesp
Pfizer
Abbott Laboratories
JNJ
Novartis
Zometa
Xgeva
Prolia
Flag link:
Novartis Execs, Cover-Ups And Jawbone Damage
Novartis Execs, Cover-Ups And Jawbone Damage
Pharmalot
Novartis
Zometa
Aredia
Flag link:
Amgen Drug Meets Primary Endpoint
Amgen Drug Meets Primary Endpoint
Yahoo/Zacks
Xgeva
Amgen
prostate cancer
Zometa
Flag link:
Novartis' Zometa Disappoints
Novartis' Zometa Disappoints
Yahoo/Zacks.com
Novartis
Zometa
AZURE
Flag link:
Something Is Better Than Nothing, I Guess (Novartis, Zometa)
Something Is Better Than Nothing, I Guess (Novartis, Zometa)
Motley Fool
Novartis
Zometa
breast cancer
Flag link:
Novartis's Failure With Zometa in Breast Cancer Stalls $1 Billion Booster
Novartis's Failure With Zometa in Breast Cancer Stalls $1 Billion Booster
Bloomberg
Novartis
breast cancer
Zometa
Flag link:
Novartis to Withdraw Expanded Zometa Approval Request After Trial Failure
Novartis to Withdraw Expanded Zometa Approval Request After Trial Failure
Bloomberg
Novartis
Zometa
breast cancer
Flag link:
Novartis Must Pay $12M Over Jaw-Bone Damage
Novartis Must Pay $12M Over Jaw-Bone Damage
Pharmalot
settlements
Novartis
Aredia
Zometa
osteoporosis
Flag link:
Novartis Officials Hid Bone Drugs' Risks, Lawyer Tells Jurors
Novartis Officials Hid Bone Drugs' Risks, Lawyer Tells Jurors
Bloomberg
Novartis
Aredia
Zometa
Flag link:
Novartis Hid Health Risks of Bone Drugs, Lawyer Tells Jury in New Jersey
Novartis Hid Health Risks of Bone Drugs, Lawyer Tells Jury in New Jersey
Bloomberg
Novartis
Zometa
Aredia
Flag link:
Amgen Gets More Good Data with Bone Drug Prolia, but Other Risks Await
Amgen Gets More Good Data with Bone Drug Prolia, but Other Risks Await
BNET Pharma
Amgen
Prolia
Novartis
Zometa
denosumab
Flag link:
Amgen Tops Novartis at Reducing Fractures in Prostate Patients
Amgen Tops Novartis at Reducing Fractures in Prostate Patients
Bloomberg
Amgen
Novartis
denosumab
prostate cancer
Zometa
Flag link:
Novartis seeks to broaden use of some cancer drugs
Novartis seeks to broaden use of some cancer drugs
Marketwatch
cancer
Novartis
Tasigna
Zometa
Flag link:
Will Novartis Be Found Guilty Of Denying Zometa Risks?
Will Novartis Be Found Guilty Of Denying Zometa Risks?
Pharmalot
Zometa
Novartis
Flag link:
Amgen reports results of trial of cancer treatment
Amgen reports results of trial of cancer treatment
Marketwatch
Amgen
cancer
denosumab
Zometa
Novartis
Flag link:
Novartis Bone Drug Cuts Risk of Breast Cancer Return in Study
Novartis Bone Drug Cuts Risk of Breast Cancer Return in Study
Bloomberg
breast cancer
Novartis
Zometa
Flag link: